Novo Nordisk renews cycling team deal; Amgen taps 'champions' of cancer;

> Novo Nordisk ($NVO) has re-upped on its sponsorship for an all-diabetes professional cycling team, extending the deal with Team Novo Nordisk to 5 years. Report

> Amgen ($AMGN) has plucked 10 "champion" cancer survivors, patients, caregivers and advocates as part of its Breakaway from Cancer awareness push; the winners will appear with Joan Lunden at the California company's Tour of California bike race. Release

> Bayer tapped a New Jersey woman, Patricia Middings, as the winner of its "Breathless Moments" photo contest, part of an awareness campaign for chronic thromboembolic pulmonary hypertension. Release

> Jordan's Hikma Pharmaceuticals launched a caffeine citrate injection, Cafcit, to treat apnea in premature infants. Report

> Sucampo Pharmaceuticals inked a deal with Gloria Pharma to sell the bowel drug Amitiza in China. Report

> Merck KGaA and its partner Threshold Pharmaceuticals won FDA fast-track review for their treatment for advanced pancreatic cancer, evofosfamide. Report

And Finally... When can doctors confidently say leukemia is "cured"? Report

Suggested Articles

AstraZeneca has had high hopes for its Imfinzi-tremelimumab pairing. But after a high-profile miss last year, the combo has struck out again.

With drug-resistant bacteria on the rise, antibiotics have struggled to keep up. But with an FDA nod for Nabriva's Xenleta, some of that may change.

JAK drugs have run into safety issues, and if the label for AbbVie's Rinvoq is any indication, the FDA now believes those the issues are class-wide.